338 related articles for article (PubMed ID: 34996416)
21. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.
Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
Hu S; Zhang Q; Sun J; Xue J; Wang C
Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
[TBL] [Abstract][Full Text] [Related]
25. miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer.
Yu C; Li B; Wang J; Zhang Z; Li S; Lei S; Wang Q
Ann Clin Lab Sci; 2021 Sep; 51(5):625-637. PubMed ID: 34686504
[TBL] [Abstract][Full Text] [Related]
26. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.
Chen H; Li F; Xue Q
Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1.
Cui X; Zhang B; Li B; Li X
Bioengineered; 2022 Apr; 13(4):9070-9085. PubMed ID: 35293280
[TBL] [Abstract][Full Text] [Related]
28. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
29. Circ_MACF1 targets miR-421 to upregulate FMO2 to suppress paclitaxel resistance and malignant cellular behaviors in lung adenocarcinoma.
Qian X; Chen C; Tong S; Zhang J
Thorac Cancer; 2023 Nov; 14(33):3348-3357. PubMed ID: 37814902
[TBL] [Abstract][Full Text] [Related]
30. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
Jin S; He J; Li J; Guo R; Shu Y; Liu P
Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
[TBL] [Abstract][Full Text] [Related]
31. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
Luo H; Peng J; Yuan Y
Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
[TBL] [Abstract][Full Text] [Related]
32. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
33. Circ_0026134 promotes NSCLC progression by the miR-3619-5p/CHAF1B axis.
Ge L; Tan W; Li G; Gong N; Zhou L
Thorac Cancer; 2022 Feb; 13(4):582-592. PubMed ID: 34985193
[TBL] [Abstract][Full Text] [Related]
34. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
Li Y; Ma Z; Luo M; Liang R
Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
[TBL] [Abstract][Full Text] [Related]
35. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating
Wang X; Wang H; Jiang H; Qiao L; Guo C
Cancer Biother Radiopharm; 2023 Jun; 38(5):293-304. PubMed ID: 34339285
[No Abstract] [Full Text] [Related]
36. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
37. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
38. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2.
Jia L; Liu M; An L; Wang H; Wang X
Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
[TBL] [Abstract][Full Text] [Related]
39. Circ_0084188 Regulates the progression of colorectal cancer through the miR-769-5p/KIF20A axis.
Zhang L; Song W; Shi J; Chen Y
Biochem Genet; 2023 Oct; 61(5):1727-1744. PubMed ID: 36763221
[TBL] [Abstract][Full Text] [Related]
40. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X
Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]